RNA Clinical Trials Resources
-
Melanoma: Global Clinical Trial Landscape - Focus On Asia Pacific
5/9/2023
Better understand the incidence, distribution, and possible control of melanoma in the Asia Pacific region, the standard of care, the trial landscape, and more.
-
Ovarian Cancer: Global Clinical Trial Landscape - Focus On Asia Pacific
5/8/2023
Better understand the incidence, distribution, and possible control of ovarian cancer (OC) in the Asia Pacific region, the standard of care, the trial landscape, and more.
-
Expert Consulting, MRCT Strategy Rescues Oncology Program
5/8/2023
Uncover how teams identified missing IB data and necessary additional details needed to outline U.S. study challenges as required for local authority approval in a previously failing study.
-
Modulate mRNA Therapy Effectiveness Using Modified Ribonucleotides
3/20/2023
Learn about the problem of immunogenicity of mRNA, modified mRNA via in vitro transcription production, and choosing fit-for-purpose modified ribonucleotides.
-
Understanding CRISPR Clinical Trials: Your Questions Answered
3/15/2023
CRISPR technology is revolutionizing cell and gene therapies, but how do CRISPR clinical trials work? Follow this explanation of CRISPR therapies from the discovery phase to FDA approval.
-
Key Challenges for CRISPR In Clinical Development
2/28/2023
Learn how to approach CRISPR cell and gene therapy development challenges, such as regulatory hurdles, ensuring consistency, finding qualified and experienced staff, and obtaining GMP-Grade reagents.
-
Leveraging Global Drug Development Programs To Ensure Trial Success
2/7/2023
Opting to take your biotech program global can help save crucial resources, produce high-quality clinical data for your therapy, and leverage unique regional advantages like region-specific indication strategies.
-
Cell & Gene Therapy In The Asia Pacific Clinical Trial Landscape
1/6/2023
Discover how a new class of therapeutics called cell and gene therapies are revolutionizing how diseases are treated and even potentially cured.
-
COVID-19: Asia Pacific Clinical Trial Landscape
9/29/2022
In December 2019, a novel coronavirus was discovered in China causing severe acute respiratory syndrome-like pneumonia which resulted in a pandemic. Find out more details regarding its spread in this report.
-
Solid Tumors: Asia Pacific Clinical Trial Landscape
9/29/2022
Read more about how the large population and lower volume of studies decreases competing trial risk in this region with a great need for novel drug therapies for solid tumors in Asian patients